Trendlines Medical Singapore is Trendlines’ third technology start-up incubator, joining Israel-based incubators Trendlines Medical and Trendlines Agtech. Trendlines Medical Singapore was established in 2016 by The Trendlines Group and B. Braun, one of the world’s leading medical device players.
Trendlines Medical Singapore operates similarly to Trendlines Medical (Israel): It discovers, invests in, incubates, and provides a range of services to nurture and develop Singapore-based entrepreneurs and start-up companies involved in novel medical devices and technologies with a view toward success in the global market.
Trendlines Medical Singapore and its shareholders believe that Singapore’s strong scientific base — supported by internationally acclaimed universities and research institutes and an excellent infrastructure of hospitals and healthcare providers — creates opportunities to develop successful medical technology companies. The primary sources for innovative technologies: Singapore’s universities, research institutes, hospitals, and entrepreneurs.
Trendlines Medical Singapore may also start companies that are based on technologies that have not necessarily originated in Singapore, including technologies developed by Trendlines Labs, Trendlines’ in-house innovation center. These companies operate from Singapore. InterVaal was established from technology developed by Labs.
Trendlines Medical Singapore is intensely involved in its portfolio companies by supporting technology development, business development, market and commercialization strategies, funding strategy, finance, and marketing communications.